Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ · Healthcare
Orchestra BioMed Holdings, Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 33.5M | 2.6M | 2.8M | 3.5M |
| Gross Profit | 33.3M | 2.4M | 2.6M | 3.3M |
| Profitability | ||||
| Operating Income | -51.8M | -64.3M | -51.5M | -32.7M |
| EBITDA | -51.5M | -64.0M | -51.2M | -32.4M |
| Net Income | -52.7M | -61.0M | -49.1M | -33.6M |
| Per Share Data | ||||
| EPS (diluted) | $-1.11 | $-1.66 | $-1.48 | $-2.24 |
| Shares Outstanding (dil.) | 48M | 37M | 33M | 15M |
Orchestra BioMed Holdings, Inc. Income Statement — FAQ
Orchestra BioMed Holdings, Inc. (OBIO) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OBIO's income statement history?
The chart and table above show Orchestra BioMed Holdings, Inc.'s income statement by year and by quarter, including the growth rate.